Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Cumberland Pharmaceuticals (CPIX) Tax Provisions: 2009-2025

Historic Tax Provisions for Cumberland Pharmaceuticals (CPIX) over the last 17 years, with Sep 2025 value amounting to $5,670.

  • Cumberland Pharmaceuticals' Tax Provisions fell 50.45% to $5,670 in Q3 2025 from the same period last year, while for Sep 2025 it was -$39,985, marking a year-over-year decrease of 167.45%. This contributed to the annual value of -$22,669 for FY2024, which is 149.53% down from last year.
  • According to the latest figures from Q3 2025, Cumberland Pharmaceuticals' Tax Provisions is $5,670, which was down 0.02% from $5,671 recorded in Q2 2025.
  • In the past 5 years, Cumberland Pharmaceuticals' Tax Provisions registered a high of $48,150 during Q4 2022, and its lowest value of -$56,996 during Q4 2024.
  • Over the past 3 years, Cumberland Pharmaceuticals' median Tax Provisions value was $6,938 (recorded in 2023), while the average stood at $3,646.
  • Its Tax Provisions has fluctuated over the past 5 years, first skyrocketed by 284.71% in 2022, then tumbled by 328.39% in 2024.
  • Quarterly analysis of 5 years shows Cumberland Pharmaceuticals' Tax Provisions stood at $12,516 in 2021, then surged by 284.71% to $48,150 in 2022, then plummeted by 48.17% to $24,956 in 2023, then plummeted by 328.39% to -$56,996 in 2024, then slumped by 50.45% to $5,670 in 2025.
  • Its Tax Provisions was $5,670 in Q3 2025, compared to $5,671 in Q2 2025 and $5,670 in Q1 2025.